These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 29164298

  • 1. Value of 18F-FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients.
    Lv Z, Fan J, Xu J, Wu F, Huang Q, Guo M, Liao T, Liu S, Lan X, Liao S, Geng W, Jin Y.
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):735-750. PubMed ID: 29164298
    [Abstract] [Full Text] [Related]

  • 2. Correlation of FDG PET/CT, tumor markers and Ki-67 index with EGFR mutation or positive ALK expression in patients with non-small cell lung cancer.
    Wang HC, Wang ZM, Hu WD, Liang XQ, Cui LL.
    Q J Nucl Med Mol Imaging; 2024 Sep; 68(3):169-175. PubMed ID: 39008330
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Semiquantitative parameters of 18F-FDG PET/CT, gene mutation states of epidermal growth factor receptor and anaplastic lymphoma kinase in prognosis evaluation of patients with lung adenocarcinoma].
    Liao XH, Wang RF, Liu M, Chen XQ, Xiong Y, Nong L, Yin L, Zhang BY, DU YJ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct 20; 53(2):246-254. PubMed ID: 33879893
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The relationship of PET/CT SUVmax with EGFR mutation status and ALK rearrangement in lung adenocarcinoma.
    Igde MH, Ozturk A, Oruc O, Oztas S, Kavas M.
    Hell J Nucl Med; 2022 Oct 20; 25(2):188-195. PubMed ID: 36030461
    [Abstract] [Full Text] [Related]

  • 12. EGFR mutation decreases FDG uptake in non‑small cell lung cancer via the NOX4/ROS/GLUT1 axis.
    Chen L, Zhou Y, Tang X, Yang C, Tian Y, Xie R, Chen T, Yang J, Jing M, Chen F, Wang C, Sun H, Huang Y.
    Int J Oncol; 2019 Jan 20; 54(1):370-380. PubMed ID: 30431083
    [Abstract] [Full Text] [Related]

  • 13. Effects of cigarette smoking on metabolic activity of lung cancer on baseline 18F-FDG PET/CT.
    Jiang M, Guo X, Zhang X, Gao Q, Mei W, Zhang J, Zheng J.
    PeerJ; 2022 Jan 20; 10():e13352. PubMed ID: 35497180
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 18F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer.
    Guan J, Xiao NJ, Chen M, Zhou WL, Zhang YW, Wang S, Dai YM, Li L, Zhang Y, Li QY, Li XZ, Yang M, Wu HB, Chen LH, Liu LY.
    Medicine (Baltimore); 2016 Jul 20; 95(30):e4421. PubMed ID: 27472739
    [Abstract] [Full Text] [Related]

  • 18. [Value of (18)F-FDG PET-CT imaging to predict epidermal growth factor receptor mutations in patients with lung squamous cell carcinoma].
    Zhao CY, Deng XY, Wang HS, Cao GP, Ding JN, Ding CY.
    Zhonghua Zhong Liu Za Zhi; 2021 Jul 23; 43(7):795-800. PubMed ID: 34289575
    [Abstract] [Full Text] [Related]

  • 19. Correlation between EGFR mutation status and F18 -fluorodeoxyglucose positron emission tomography-computed tomography image features in lung adenocarcinoma.
    Zhu L, Yin G, Chen W, Li X, Yu X, Zhu X, Jiang W, Jia C, Chen P, Zhang Y, Lu D, Yu L, Li X, Xu W.
    Thorac Cancer; 2019 Apr 23; 10(4):659-664. PubMed ID: 30776196
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.